OncoVista Innovative Therapies, Inc.Company Review & Valuation

OVIT
OTC Markets
Latest Price
0.03USD
Market Capitalization
706.76kUSD

About OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukeShow moremias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.Show less

Industry
Biotechnology
HQ Location
San Antonio, Texas

Stock Price

Price data not available for OncoVista Innovative Therapies, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

UCB
ACADIA Pharmaceuticals
Acorda Therapeutics
Grifols

back to top